Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,258 | 258 | 92.9% |
| Education | $401.12 | 5 | 7.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $487.44 | 22 | $0 (2024) |
| Astellas Pharma US Inc | $416.44 | 13 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $387.04 | 17 | $0 (2024) |
| Ipsen Biopharmaceuticals, Inc | $264.31 | 12 | $0 (2024) |
| PFIZER INC. | $262.93 | 13 | $0 (2024) |
| Merck Sharp & Dohme LLC | $249.07 | 13 | $0 (2024) |
| Incyte Corporation | $238.94 | 14 | $0 (2024) |
| Eisai Inc. | $223.65 | 11 | $0 (2024) |
| Seagen Inc. | $201.08 | 6 | $0 (2023) |
| Janssen Biotech, Inc. | $197.34 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,604 | 124 | AstraZeneca Pharmaceuticals LP ($318.59) |
| 2023 | $2,197 | 98 | Astellas Pharma US Inc ($283.86) |
| 2022 | $758.19 | 40 | Novartis Pharmaceuticals Corporation ($83.69) |
| 2021 | $99.95 | 1 | Seagen Inc. ($99.95) |
All Payment Transactions
263 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Pharmacosmos Therapeutics Inc. | MONOFERRIC (Drug) | Food and Beverage | In-kind items and services | $19.54 | General |
| Category: HEMATOLOGY | ||||||
| 12/18/2024 | Deciphera Pharmaceuticals Inc. | QINLOCK (Drug), TGCT | Food and Beverage | In-kind items and services | $19.72 | General |
| Category: ONCOLOGY | ||||||
| 12/17/2024 | Geron Corporation | RYTELO (Drug) | Food and Beverage | In-kind items and services | $18.50 | General |
| Category: MYELODYSPLASTIC SYNDROME | ||||||
| 12/11/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $23.30 | General |
| 12/09/2024 | Astellas Pharma US Inc | Padcev (Drug) | Food and Beverage | In-kind items and services | $18.35 | General |
| Category: Oncology | ||||||
| 12/04/2024 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $0.47 | General |
| Category: Hematology/Oncology | ||||||
| 12/03/2024 | Karyopharm Therapeutics Inc. | XPOVIO (Drug) | Food and Beverage | In-kind items and services | $22.09 | General |
| Category: Oncology | ||||||
| 12/03/2024 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $19.16 | General |
| Category: Hematology/Oncology | ||||||
| 12/03/2024 | PFIZER INC. | INLYTA (Drug), PADCEV | Food and Beverage | In-kind items and services | $17.65 | General |
| Category: ONCOLOGY | ||||||
| 11/27/2024 | Novocure Inc. | Optune Lua (NovoTTF-200T) (Device) | Food and Beverage | Cash or cash equivalent | $19.23 | General |
| Category: Oncology | ||||||
| 11/26/2024 | Lilly USA, LLC | VERZENIO (Drug), JAYPIRCA | Food and Beverage | In-kind items and services | $20.33 | General |
| Category: Oncology | ||||||
| 11/25/2024 | SOBI, INC | DOPTELET (Drug) | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 11/21/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $17.28 | General |
| Category: ONCOLOGY | ||||||
| 11/19/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $19.53 | General |
| Category: Oncology | ||||||
| 11/18/2024 | PFIZER INC. | TALZENNA (Drug), XTANDI | Food and Beverage | In-kind items and services | $9.68 | General |
| Category: ONCOLOGY | ||||||
| 11/15/2024 | Ipsen Biopharmaceuticals, Inc | Onivyde (Drug) | Food and Beverage | In-kind items and services | $26.26 | General |
| Category: Oncology | ||||||
| 11/13/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $22.85 | General |
| Category: Oncology | ||||||
| 11/12/2024 | Genentech USA, Inc. | Columvi (Biological), Itovebi, Lunsumio | Food and Beverage | In-kind items and services | $18.86 | General |
| Category: BioOncology | ||||||
| 11/08/2024 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $28.73 | General |
| Category: Oncology | ||||||
| 11/07/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $24.67 | General |
| 11/06/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $26.32 | General |
| Category: Oncology | ||||||
| 11/05/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $27.60 | General |
| Category: Oncology | ||||||
| 10/30/2024 | Stemline Therapeutics Inc. | ELZONRIS (Drug) | Food and Beverage | In-kind items and services | $26.25 | General |
| Category: Oncology | ||||||
| 10/29/2024 | Janssen Biotech, Inc. | RYBREVANT (Drug) | Food and Beverage | In-kind items and services | $19.62 | General |
| Category: Oncology | ||||||
| 10/28/2024 | Legend Biotech USA Inc. | — | Food and Beverage | In-kind items and services | $18.44 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 253 | 519 | $95,000 | $38,254 |
| 2022 | 2 | 218 | 552 | $103,950 | $43,209 |
| 2021 | 3 | 240 | 494 | $87,925 | $36,346 |
| 2020 | 2 | 217 | 429 | $76,750 | $27,405 |
All Medicare Procedures & Services
9 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 135 | 343 | $68,600 | $28,058 | 40.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 118 | 176 | $26,400 | $10,197 | 38.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 136 | 423 | $84,600 | $35,823 | 42.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 82 | 129 | $19,350 | $7,385 | 38.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 113 | 249 | $49,800 | $20,861 | 41.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 116 | 234 | $35,100 | $14,106 | 40.2% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 11 | 11 | $3,025 | $1,378 | 45.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 112 | 248 | $49,600 | $18,280 | 36.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 105 | 181 | $27,150 | $9,125 | 33.6% |
About Hillary Flaherty, NP
Hillary Flaherty, NP is a Family healthcare provider based in North Chesterfield, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/07/2012. The National Provider Identifier (NPI) number assigned to this provider is 1194079590.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Hillary Flaherty, NP has received a total of $5,659 in payments from pharmaceutical and medical device companies, with $2,604 received in 2024. These payments were reported across 263 transactions from 59 companies. The most common payment nature is "Food and Beverage" ($5,258).
As a Medicare-enrolled provider, Flaherty has provided services to 928 Medicare beneficiaries, totaling 1,994 services with total Medicare billing of $145,213. Data is available for 4 years (2020–2023), covering 9 distinct procedure/service records.
Practice Information
- Specialty Family
- Location North Chesterfield, VA
- Active Since 11/07/2012
- Last Updated 05/24/2021
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1194079590
Products in Payments
- KEYTRUDA (Biological) $249.07
- Lenvima (Drug) $223.65
- Onivyde (Drug) $200.23
- JEVTANA (Drug) $180.86
- JAKAFI (Drug) $172.05
- IMBRUVICA (Drug) $165.41
- LYNPARZA (Drug) $154.42
- TAGRISSO (Drug) $148.09
- SCEMBLIX (Drug) $143.95
- KISQALI (Drug) $126.33
- REBLOZYL (Biological) $114.38
- LONSURF (Drug) $101.86
- VERZENIO (Drug) $99.03
- INLYTA (Drug) $96.60
- CALQUENCE (Drug) $86.64
- Xospata (Drug) $83.18
- FRUZAQLA (Drug) $80.49
- TIVDAK (Biological) $80.01
- PADCEV (Biological) $79.66
- XPOVIO (Drug) $78.53
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in North Chesterfield
Kara Foster-Weiss, M,D, M,D
Family — Payments: $20,387
Anila Abraham, Np, NP
Family — Payments: $6,678
Mrs. Emily Kane, Aprn, APRN
Family — Payments: $4,676
Caitlin Halpin, Aprn, APRN
Family — Payments: $2,742
Kenjilyn Ares, Fnp-C, FNP-C
Family — Payments: $1,407
Terry Smith, Fnp-Bc, FNP-BC
Family — Payments: $1,293